These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 7810335)

  • 1. Participation of prostaglandins and bradykinin in the effects of angiotensin II and converting enzyme-inhibition on sympathetic neurotransmission in vivo.
    Schwieler JH; Kahan T; Nussberger J; Hjemdahl P
    Acta Physiol Scand; 1994 Sep; 152(1):83-91. PubMed ID: 7810335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Converting enzyme inhibition modulates sympathetic neurotransmission in vivo via multiple mechanisms.
    Schwieler JH; Kahan T; Nussberger J; Hjemdahl P
    Am J Physiol; 1993 Apr; 264(4 Pt 1):E631-7. PubMed ID: 8386457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of angiotensin II, alpha- and beta-adrenoceptors on peripheral noradrenergic neurotransmission in canine gracilis muscle in vivo.
    Schwieler JH; Kahan T; Nussberger J; Johansson MC; Hjemdahl P
    Acta Physiol Scand; 1992 Aug; 145(4):333-43. PubMed ID: 1326853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prejunctional adrenergic receptors and sympathetic neurotransmission: studies in canine skeletal muscle vasculature in situ.
    Kahan T
    Acta Physiol Scand Suppl; 1987; 560():1-38. PubMed ID: 2884804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the renin-angiotensin system on sympathetic neurotransmission in canine skeletal muscle in vivo.
    Schwieler JH; Kahan T; Nussberger J; Hjemdahl P
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Feb; 343(2):166-72. PubMed ID: 1648672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible involvement of neuropeptide Y in sympathetic vascular control of canine skeletal muscle.
    Pernow J; Kahan T; Hjemdahl P; Lundberg JM
    Acta Physiol Scand; 1988 Jan; 132(1):43-50. PubMed ID: 2906210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of angiotensin-converting enzyme inhibition on sympathetic neurotransmission: possible roles of bradykinin and prostaglandins.
    Schwieler JH; Hjemdahl P
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S39-46. PubMed ID: 1282628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.
    Hartman JC
    Ann Thorac Surg; 1995 Sep; 60(3):789-92. PubMed ID: 7545893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of presynaptic sympathetic activity by kinins and related compounds: influence of converting enzyme inhibition.
    Dominiak P; Simon M; Blöchl A; Brenner P
    Agents Actions Suppl; 1992; 38 ( Pt 3)():52-61. PubMed ID: 1462884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noradrenaline release evoked by a physiological irregular sympathetic discharge pattern is modulated by prejunctional alpha- and beta-adrenoceptors in vivo.
    Kahan T; Pernow J; Schwieler J; Wallin BG; Lundberg JM; Hjemdahl P
    Br J Pharmacol; 1988 Dec; 95(4):1101-8. PubMed ID: 2851357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of the renin-angiotensin system, bradykinin and sympathetic nerves with cholinergic transmission in the rat isolated trachea.
    Fabiani ME; Dinh DT; Story DF
    Br J Pharmacol; 1997 Nov; 122(6):1089-98. PubMed ID: 9401774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-release and functional interactions of neuropeptide Y and noradrenaline in peripheral sympathetic vascular control.
    Pernow J
    Acta Physiol Scand Suppl; 1988; 568():1-56. PubMed ID: 3232527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of sympathetic control by ACE inhibitors.
    Dominiak P
    Eur Heart J; 1993 Nov; 14 Suppl I():169-72. PubMed ID: 8293770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local inhibition of bradykinin degradation in ischemic hearts.
    Linz W; Martorana PA; Schölkens BA
    J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S99-109. PubMed ID: 1697370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release and vasoconstrictor effects of neuropeptide Y in relation to non-adrenergic sympathetic control of renal blood flow in the pig.
    Pernow J; Lundberg JM
    Acta Physiol Scand; 1989 Aug; 136(4):507-17. PubMed ID: 2571235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation by ACE inhibitors of the dilator response to bradykinin in the coronary microcirculation: interaction at the receptor level.
    Hecker M; Pörsti I; Bara AT; Busse R
    Br J Pharmacol; 1994 Jan; 111(1):238-44. PubMed ID: 8012702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bradykinin B2-receptor-mediated stimulation of exocytotic noradrenaline release from cardiac sympathetic neurons.
    Kurz T; Tölg R; Richardt G
    J Mol Cell Cardiol; 1997 Sep; 29(9):2561-9. PubMed ID: 9299378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of myocardial stunning by the ACE inhibitor ramiprilat through a signal cascade of bradykinin and prostaglandins but not nitric oxide.
    Ehring T; Baumgart D; Krajcar M; Hümmelgen M; Kompa S; Heusch G
    Circulation; 1994 Sep; 90(3):1368-85. PubMed ID: 8087948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local action of the renin angiotensin system in the porcine ophthalmic circulation: effects of ACE-inhibitors and angiotensin receptor antagonists.
    Meyer P; Flammer J; Lüscher TF
    Invest Ophthalmol Vis Sci; 1995 Mar; 36(3):555-62. PubMed ID: 7890486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-myo-inositol-1,2,6-triphosphate (PP56) antagonizes nonadrenergic sympathetic vasoconstriction: possible involvement of neuropeptide Y.
    Schwieler JH; Hjemdahl P
    J Cardiovasc Pharmacol; 1993 Mar; 21(3):347-52. PubMed ID: 7681493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.